Inhouse product
Indications
Hemorif is indicated
in the treatment of-
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Composition
Each film coated
tablet contains-
Each DS film coated
tablet contains-
Pharmacology
Diosmin and Hesperidin
is a phlebotonic drug and a vascular protecting agent. It reinforces venous
tone by prolonging the activity of parietal noradrenaline. Thus Diosmin and
Hesperidin decreases venous capacitance, venous distensibility, and venous
emptying time.
Diosmin and Hesperidin protects the microcirculation by fighting the
microcirculation damaging process; It combats venous inflammation by decreasing
leukocyte activation, and as a consequence, by inhibiting the release of
inflammatory mediators, principally free radicals and prostaglandin. Thus
Diosmin and Hesperidin normalizes capillary permeability and strengthens
capillary resistance.
Diosmin and Hesperidin acts on the lymphatic system, It improves lymphatic
drainage by increasing lymph flow and lymph oncotic pressure.
Dosage
Diosmin 450 mg &
Hesperidin 50 mg-
Diosmin 900 mg &
Hesperidin 100 mg-
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Administration
Tablet should be taken
at meal times.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Interaction
No evidence of drug
incompatibility (drug interaction) has been reported in clinical trials.
Contraindications
Chronic venous
insufficiency and its complications should be diagnosed and management
monitored by a physician. It is contraindicated for anyone having a
hypersensitivity to any ingredient in the product.
Side Effects
Some cases of routine
gastric disorders and neurovegetative disorders (feeling of discomfort) have
been reported. In this cases discontinuation of treatment is not required.
Pregnancy & Lactation
Experimental studies
have not shown any teratogenic effect in animals. In human beings, no harmful
effect has so far been reported. In the absence of data concerning excretion
into breast milk, breast feeding is not recommended during treatment.
Precautions & Warnings
If the hemorrhoidal
symptoms do not disappear within 15 days, patient should ask doctor for advice.
Diosmin (up to 900 mg/day) has been administered to a small number of breast
cancer patients who were experiencing lymphedema following surgical and nodal
irradiation treatment with resultant reduction of arm edema but no effect on
the cancer. Animal studies and more than 20 years of clinical use in Europe
have not found any evidence of carcinogenicity or mutagenicity when the
components of Diosmin & Hesperidin are used as recommended. As a
precaution, Diosmin & Hesperidin is not recommended for patients with a
history of cancer since no specific studies have been performed in this
population.
Therapeutic Class
Phlebotonic &
Vascular protecting preparation
Storage Conditions
Keep below 30°C
temperature, away from light & moisture. Keep out of the reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet